107 related articles for article (PubMed ID: 30247090)
1. A liposome preparation based on β-CD-LPC molecule and its application as drug-delivery system.
Cai A; Wang C; Yan M; Ma L; Liu W; Li F; Liu T; Song P; Gao Z; Li J; Xin M; Wei G
Nanomedicine (Lond); 2018 Nov; 13(21):2777-2789. PubMed ID: 30247090
[TBL] [Abstract][Full Text] [Related]
2. Preparation of β-CD-DPPE-Dox Nanomedicine and Its' Application as the Anticancer and Antitumor Drug.
Yan M; Cai A; Li J; Xin M; Liu M; Wang C; Wei G
Sci Rep; 2019 Sep; 9(1):13670. PubMed ID: 31541178
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of β-cyclodextrin-PEG-G molecules to delay tumor growth and application of β-cyclodextrin-PEG-G aggregates as drug carrier.
Li J; Xin M; Huo Y; Cai A; Yan M; Wang C; Wei G
Carbohydr Polym; 2020 Feb; 229():115478. PubMed ID: 31826440
[TBL] [Abstract][Full Text] [Related]
4. Palmitoyl ascorbate and doxorubicin co-encapsulated liposome for synergistic anticancer therapy.
Yang Y; Lu X; Liu Q; Dai Y; Zhu X; Wen Y; Xu J; Lu Y; Zhao D; Chen X; Li N
Eur J Pharm Sci; 2017 Jul; 105():219-229. PubMed ID: 28526602
[TBL] [Abstract][Full Text] [Related]
5. Enhanced anti-cancer efficacy to cancer cells by doxorubicin loaded water-soluble amino acid-modified β-cyclodextrin platinum complexes.
Zhao MX; Zhao M; Zeng EZ; Li Y; Li JM; Cao Q; Tan CP; Ji LN; Mao ZW
J Inorg Biochem; 2014 Aug; 137():31-9. PubMed ID: 24803024
[TBL] [Abstract][Full Text] [Related]
6. Development of self-forming doxorubicin-loaded polymeric depots as an injectable drug delivery system for liver cancer chemotherapy.
Nittayacharn P; Nasongkla N
J Mater Sci Mater Med; 2017 Jul; 28(7):101. PubMed ID: 28534285
[TBL] [Abstract][Full Text] [Related]
7. mPEGylated solanesol micelles as redox-responsive nanocarriers with synergistic anticancer effect.
Qin B; Liu L; Wu X; Liang F; Hou T; Pan Y; Song S
Acta Biomater; 2017 Dec; 64():211-222. PubMed ID: 28963017
[TBL] [Abstract][Full Text] [Related]
8. pH-responsive unimolecular micelle-gold nanoparticles-drug nanohybrid system for cancer theranostics.
Lin W; Yao N; Qian L; Zhang X; Chen Q; Wang J; Zhang L
Acta Biomater; 2017 Aug; 58():455-465. PubMed ID: 28583900
[TBL] [Abstract][Full Text] [Related]
9. Hyaluronic acid modified pH-sensitive liposomes for targeted intracellular delivery of doxorubicin.
Paliwal SR; Paliwal R; Agrawal GP; Vyas SP
J Liposome Res; 2016 Dec; 26(4):276-87. PubMed ID: 26784587
[TBL] [Abstract][Full Text] [Related]
10. One-pot fabrication of pH/reduction dual-stimuli responsive chitosan-based supramolecular nanogels for leakage-free tumor-specific DOX delivery with enhanced anti-cancer efficacy.
Li J; Liu P
Carbohydr Polym; 2018 Dec; 201():583-590. PubMed ID: 30241856
[TBL] [Abstract][Full Text] [Related]
11. Intracellular redox-activated anticancer drug delivery by functionalized hollow mesoporous silica nanoreservoirs with tumor specificity.
Luo Z; Hu Y; Cai K; Ding X; Zhang Q; Li M; Ma X; Zhang B; Zeng Y; Li P; Li J; Liu J; Zhao Y
Biomaterials; 2014 Sep; 35(27):7951-62. PubMed ID: 24930850
[TBL] [Abstract][Full Text] [Related]
12. The antitumor activity of tumor-homing peptide-modified thermosensitive liposomes containing doxorubicin on MCF-7/ADR: in vitro and in vivo.
Wang C; Wang X; Zhong T; Zhao Y; Zhang WQ; Ren W; Huang D; Zhang S; Guo Y; Yao X; Tang YQ; Zhang X; Zhang Q
Int J Nanomedicine; 2015; 10():2229-48. PubMed ID: 25834435
[TBL] [Abstract][Full Text] [Related]
13. Selenium-functionalized liposomes for systemic delivery of doxorubicin with enhanced pharmacokinetics and anticancer effect.
Xie Q; Deng W; Yuan X; Wang H; Ma Z; Wu B; Zhang X
Eur J Pharm Biopharm; 2018 Jan; 122():87-95. PubMed ID: 29032193
[TBL] [Abstract][Full Text] [Related]
14. Facile Synthesis of Fluorescent Hyper-Cross-Linked β-Cyclodextrin-Carbon Quantum Dot Hybrid Nanosponges for Tumor Theranostic Application with Enhanced Antitumor Efficacy.
Pei M; Pai JY; Du P; Liu P
Mol Pharm; 2018 Sep; 15(9):4084-4091. PubMed ID: 30040427
[TBL] [Abstract][Full Text] [Related]
15. Thermosensitive magnetic liposomes with doxorubicin cell-penetrating peptides conjugate for enhanced and targeted cancer therapy.
Lin W; Xie X; Yang Y; Fu X; Liu H; Yang Y; Deng J
Drug Deliv; 2016 Nov; 23(9):3436-3443. PubMed ID: 27193383
[TBL] [Abstract][Full Text] [Related]
16. Biocompatible cellulose-based supramolecular nanoparticles driven by host-guest interactions for drug delivery.
Yang X; Jiang X; Yang H; Bian L; Chang C; Zhang L
Carbohydr Polym; 2020 Jun; 237():116114. PubMed ID: 32241406
[TBL] [Abstract][Full Text] [Related]
17. Thermo-Sensitive Liposome co-Loaded of Vincristine and Doxorubicin Based on Their Similar Physicochemical Properties had Synergism on Tumor Treatment.
Li M; Li Z; Yang Y; Wang Z; Yang Z; Li B; Xie X; Song J; Zhang H; Li Y; Gao G; Yang J; Mei X; Gong W
Pharm Res; 2016 Aug; 33(8):1881-98. PubMed ID: 27075873
[TBL] [Abstract][Full Text] [Related]
18. Photo- and pH- Dual-Responsive β-Cyclodextrin-Based Supramolecular Prodrug Complex Self-Assemblies for Programmed Drug Delivery.
Bai Y; Liu CP; Song X; Zhuo L; Bu H; Tian W
Chem Asian J; 2018 Dec; 13(24):3903-3911. PubMed ID: 30311448
[TBL] [Abstract][Full Text] [Related]
19. Biocompatible cationic pullulan-g-desoxycholic acid-g-PEI micelles used to co-deliver drug and gene for cancer therapy.
Chen L; Ji F; Bao Y; Xia J; Guo L; Wang J; Li Y
Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):418-429. PubMed ID: 27770912
[TBL] [Abstract][Full Text] [Related]
20. Targeted delivery of doxorubicin using stealth liposomes modified with transferrin.
Li X; Ding L; Xu Y; Wang Y; Ping Q
Int J Pharm; 2009 May; 373(1-2):116-23. PubMed ID: 19429296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
